ArticleCureus2025
Use of a Vertical Traction Device in the Management of an Open Abdomen: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- FasciotensHernia : the journal of hernias and abdominal wall surgery · 2026Pooled it
- Severe trauma care: advances and future directions in diagnostic and therapeutic techniques and information technology support.Medical review (2021) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A laparostomy procedure, a critical intervention frequently employed in both trauma and non-trauma patients, is a key component of damage control resuscitation. The use of a vertical traction device (VTD), specifically Fasciotens® Abdomen (FTA), is a relatively novel technology that prevents fascial retraction and facilitates primary fascial closure. This report describes the case of a male in his 20s with severe pancreatitis, complicated by multi-organ failure and abdominal compartment syndrome (ACS), necessitating decompressive laparotomy. FTA was applied alongside botulinum toxin (Botox) and negative pressure wound therapy (NPWT), achieving definitive closure within 10 days. Fascial distance was reduced by 8 cm within 48 hours of FTA application. This case highlights FTA's efficacy and safety, supported by the Liverpool Hospital Trauma Acute Care Surgery (TACS) wound bundle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.